A phase II study of loratidine (L) to prevent pegfilgrastim-induced pain (PIP).Jeffrey J. Kirshner, G Morrow, Christin M. Giordano McAuliffe et al.|Journal of Clinical Oncology|2011Cited by 5
A phase II study of loratidine (L) and naproxen (N) to prevent pegfilgrastim-induced pain (PIP).Jeffrey J. Kirshner, Gary R. Morrow, Charles E. Heckler et al.|Journal of Clinical Oncology|2012Cited by 2